Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1843778 | 1.00 | BLM (0.41) | BLMKMT2AALOX15PMP22ALDH1A1 | |
| SCHEMBL10355086 | 0.86 | SLC6A2 (0.41) | BLMKMT2AALDH1A1SLC6A2SLC6A4 | |
| SCHEMBL28959981 | 0.84 | BLM (0.42) | BLMKMT2AALOX15PMP22ALDH1A1 | |
| SCHEMBL28959979 | 0.84 | BLM (0.42) | BLMKMT2AALOX15PMP22ALDH1A1 | |
| SCHEMBL757318 | 0.82 | GRIK1 (0.31) | ALDH1A1 | |
| SCHEMBL5696080 | 0.81 | BLM (0.40) | BLMKMT2AALOX15PMP22ALDH1A1 | |
| SCHEMBL8658486 | 0.81 | BLM (0.40) | BLMKMT2AALOX15PMP22ALDH1A1 | |
| SCHEMBL5696078 | 0.81 | BLM (0.40) | BLMKMT2AALOX15PMP22ALDH1A1 | |
| SCHEMBL3335954 | 0.77 | ALOX15 (0.45) | BLMKMT2AALOX15PMP22SLC6A3 | |
| SCHEMBL1221384 | 0.77 | ALOX15 (0.45) | BLMKMT2AALOX15PMP22SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150099808-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | NIRVANA'S TREE HOUSE B.V. (NL) | 2015-04-09 | — | — | US | claimed |
| JP-2011529100-A | — | — | 2011-12-01 | — | — | JP | claimed |
| US-20110182813-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | NIRVANA'S TREE HOUSE B.V. (NL) | 2011-07-28 | — | — | US | claimed |
| EP-2317990-A2 | MICROPARTICULATE ORAL DRUG FORM USEFUL FOR THE MODIFIED RELEASE OF NANOPARTICLES | Flamel Technologies (FR) | 2011-05-11 | — | — | EP | claimed |
| EP-2195366-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | Nirvana's Tree House B.v. (NL) | 2010-06-16 | — | — | EP | claimed |
| WO-2010012940-A2 | MICROPARTICULATE ORAL DRUG FORM USEFUL FOR THE MODIFIED RELEASE OF NANOPARTICLES | FLAMEL TECHNOLOGIES (FR) | 2010-02-04 | — | — | WO | claimed |
| US-20100021549-A1 | Microparticle oral form useful for the modified release of nanoparticles | FLAMEL TECHNOLOGIES, S.A. (FR) | 2010-01-28 | — | — | US | claimed |
| WO-2009037313-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | NIRVANA'S TREE HOUSE B.V. (NL) | 2009-03-26 | — | — | WO | claimed |
| US-4116949-A | WATER-SOLUBLE, PHYSIOLOGICALLY ACTIVE, SYNTHETIC COPOLYPEPTIDES | THE REAGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1978-09-26 | — | — | US | claimed |
| JP-62258703-A | — | — | None | — | — | JP | disclosed |
| US-20240116895-A1 | ESTER SUBSTITUTED ION CHANNEL BLOCKERS AND METHODS FOR USE | NOCION THERAPEUTICS INC (US) | 2024-04-11 | — | — | US | disclosed |
| US-20240100032-A1 | Charged Ion Channel Blockers and Methods for Use | NOCION THERAPEUTICS INC (US) | 2024-03-28 | — | — | US | disclosed |
| EP-3485881-B1 | PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI-INFLAMMATORY AGENTS | HARVARD COLLEGE (US) | 2024-03-13 | — | — | EP | disclosed |
| US-20240076305-A1 | Phosphonium Ion Channel Blockers and Methods for Use | NOCION THERAPEUTICS INC (US) | 2024-03-07 | — | — | US | disclosed |
| EP-0245820-A2 | Biodegradable microspheres as a carrier for macromolecules | The University of Kentucky Research Foundation (US) | 1987-11-19 | — | — | EP | disclosed |
| JP-S62258703-A | MEMBRANE FOR SEPARATING SACCHARIDE | AGENCY OF IND SCIENCE & TECHNOL | 1987-11-11 | — | — | JP | disclosed |
| EP-0167828-A1 | A man-made skin composed of two layers:Collagen and a poly-alpha-amino acid | KOKEN CO. LTD. (JP) | 1986-01-15 | — | — | EP | disclosed |
| EP-0164569-A2 | A medicine-releasing agent | KOKEN CO. LTD. (JP) | 1985-12-18 | — | — | EP | disclosed |
| US-4125519-A | Polypeptides containing 3,4-dihydroxyphenylalanine | GOODMAN MURRAY | 1978-11-14 | — | — | US | disclosed |
| US-4116949-A | WATER-SOLUBLE, PHYSIOLOGICALLY ACTIVE, SYNTHETIC COPOLYPEPTIDES | THE REAGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100021549-A1 | Microparticle oral form useful for the modified release of nanoparticles | MC1R, PTMS, MRPL37 | BLM 4391/4885KMT2A 4857/4885ALOX15 1826/4885 |
| US-20110182813-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | GLUL, ASNS, ARGLU1 | BLM 2609/4885KMT2A 1839/4885ALOX15 3313/4885 |
| US-20150099808-A1 | AMPHIPHILIC COPOLYMERS AND COMPOSITIONS CONTAINING SUCH POLYMERS | GLUL, ASNS, ARGLU1 | BLM 2609/4885KMT2A 1839/4885ALOX15 3313/4885 |
| US-20240100032-A1 | Charged Ion Channel Blockers and Methods for Use | TRPV1, ASIC1, TRPA1 | BLM 2975/4885KMT2A 3122/4885ALOX15 1142/4885 |
| US-20240116895-A1 | ESTER SUBSTITUTED ION CHANNEL BLOCKERS AND METHODS FOR USE | TRPV1, TRPA1, TRPV2 | BLM 4244/4885KMT2A 2763/4885ALOX15 287/4885 |
| US-20240076305-A1 | Phosphonium Ion Channel Blockers and Methods for Use | TRPV1, TRPV5, TRPA1 | BLM 4437/4885KMT2A 3568/4885ALOX15 517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.